Diabetes
The new product adds night-time alarms, making the low-cost 14-day CGM more useful.
The market comprised $98 million in revenue during 2017, and is beginning to move away from stand-alone devices or apps.
Realtime blood glucose information will allow Livongo's platform to deliver more insights, coaching to people with diabetes.